Home NDC 61919-543 ATORVASTATIN CALCIUM
Product NDC 61919-543
11-digit product format 619190543
Labeler code 61919
Product ID 61919-543_9b0a06e7-09fc-4e32-a538-b2ff433d88dd
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name ATORVASTATIN CALCIUM
Dosage form TABLET, FILM COATED
Route ORAL
Labeler DirectRX
Application ANDA091650
Marketing category ANDA
Marketing start 2015-01-01
Marketing end 0000-00-00
Substance ATORVASTATIN CALCIUM
Active strength 40 mg/1
Pharmacologic classes HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag E
Listing certified through 2017-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 44 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 61919-543-30 I Inactivated by FDA d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 61919-543-30 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 61919-543-30 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 61919-543-30 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 61919-543-30 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 61919-543-30 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 61919-543-30 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 61919-543-30 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 61919-543-30 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 61919-543-30 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 61919-543-30 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 61919-543-30 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 61919-543-30 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 61919-543-30 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 61919-543-30 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 61919-543-30 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 61919-543-30 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 61919-543-30 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 61919-543-30 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 61919-543-30 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 61919-543-30 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 61919-543-30 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091650-001 ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 A091650-002 ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 A091650-003 ATORVASTATIN CALCIUM ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091650-002 ATORVASTATIN CALCIUM EQ 20MG BASE TABLET / ORAL AB 2012-07-17 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091650-003 ATORVASTATIN CALCIUM EQ 40MG BASE TABLET / ORAL AB 2012-07-17 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091650-001 ATORVASTATIN CALCIUM EQ 10MG BASE TABLET / ORAL AB 2012-07-17 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 61919-543-30 ATORVASTATIN CALCIUM 30 in 1 BOTTLE TABLET, FILM COATED 30 1
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded Atorvastatin Calcium ACTIVE INGREDIENT 48A5M73Z4Q ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 ATORVASTATIN ACTIVE MOIETY A0JWA85V8F ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 crospovidone INACTIVE INGREDIENT 68401960MK ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 Hydroxypropyl Cellulose (Type H) INACTIVE INGREDIENT RFW2ET671P ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 isopropyl alcohol INACTIVE INGREDIENT ND2M416302 ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 lactose monohydrate INACTIVE INGREDIENT EWQ57Q8I5X ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 magnesium stearate INACTIVE INGREDIENT 70097M6I30 ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 methyl alcohol INACTIVE INGREDIENT Y4S76JWI15 ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 methylene chloride INACTIVE INGREDIENT 588X2YUY0A ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 POLYETHYLENE GLYCOLS INACTIVE INGREDIENT 3WJQ0SDW1A ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 sodium bicarbonate INACTIVE INGREDIENT 8MDF5V39QO ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 sodium lauryl sulfate INACTIVE INGREDIENT 368GB5141J ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 61919-543 ATORVASTATIN CALCIUM TABLET, FILM COATED [DIRECTRX] 1 Legacy NDC, 1 package rows 20151029_93e8183a-37b3-48d5-a510-41c35a093f0c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Status 61919-543-30 61919054330 30 in 1 BOTTLE Historical